ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

JBTMarel shares sink to 52-week low amid earnings miss

JBTMarel’s stock fell to $113.60, extending a year-long decline after a quarterly earnings shortfall and operational disruptions. Shares are down 33% from their 52-week high.

PA
Priya Anand · Equities & Earnings Desk · 24 Aug 2026 · 15:23 · 1 min read
Share
JBTMarel shares sink to 52-week low amid earnings miss

JBTMarel Corp’s stock fell to a 52-week low of $113.60 on Tuesday, extending a prolonged decline as the company posted adjusted earnings below Wall Street expectations. The shares last traded at $113.96, down $2.90, or 2.48%, marking a 21.29% drop over the past 12 months.

The decline follows a second-quarter earnings report that missed analyst projections, with adjusted earnings of $1.95 per share against a consensus forecast of $2.02 per share. Revenue totaled $981 million, below the estimated $988.43 million. The company cited operational disruptions in parts of its business as a contributing factor to the underperformance.

Despite the earnings shortfall, JBTMarel maintained its full-year outlook. Orders exceeded $1 billion for the third consecutive quarter, signaling sustained demand in its core markets. The stock’s decline has been steep, with shares down 33% from their 52-week high of $170.19 and 28.5% lower over the past six months.

JBTMarel’s valuation metrics remain notably low, with a PEG ratio of 0.15, according to InvestingPro. The company’s shares are currently ranked among the platform’s most undervalued, reflecting a low price-to-earnings ratio relative to near-term earnings growth expectations.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT